<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132879">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02002078</url>
  </required_header>
  <id_info>
    <org_study_id>ClinicalTrials.gov</org_study_id>
    <nct_id>NCT02002078</nct_id>
  </id_info>
  <brief_title>Caustic Esophageal Burns in Children and High Doses of Methylprednisolone</brief_title>
  <official_title>High Doses of Methylprednisolone in the Management of Caustic Esophageal Burns in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sisli Etfal Training &amp; Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sisli Etfal Training &amp; Research Hospital</source>
  <oversight_info>
    <authority>Turkey: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Corrosive substance ingestion in childhood is a public health issue in developing countries
      and several management protocols were proposed to prevent esophageal strictures. The role of
      corticosteroids in preventing corrosive-induced strictures is controversial. The
      investigators' aim is to study the influence of high doses of corticosteroids to prevent
      esophageal strictures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">December 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Evaluation of stricture development in children with caustic esophageal burns after high doses of methylprednisolone</measure>
    <time_frame>three years</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>stricture development was evaluated with endoscopic examination and upper gastrointestinal system series with barium swallow</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Esophageal Diseases</condition>
  <arm_group>
    <arm_group_label>Methylprednisolone, caustic burns</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>methylprednisolon</intervention_name>
    <arm_group_label>Methylprednisolone, caustic burns</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Corrosive substance ingested children with grade IIb esophageal burn

        Exclusion Criteria:

          -  Caustic substance ingested chldren grade I, IIa and grade III esophageal burns

          -  Caustic subtance ingested children with signs of perforation, mediastinitis,
             peritonitis, sespis

          -  Caustic substance ingested children with any chronic disease
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>November 28, 2013</lastchanged_date>
  <firstreceived_date>November 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sisli Etfal Training &amp; Research Hospital</investigator_affiliation>
    <investigator_full_name>Merve Usta</investigator_full_name>
    <investigator_title>DR</investigator_title>
  </responsible_party>
  <keyword>caustic</keyword>
  <keyword>corticosteroid therapy</keyword>
  <keyword>stricture</keyword>
  <keyword>children</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophageal Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Methylprednisolone acetate</mesh_term>
    <mesh_term>Prednisolone acetate</mesh_term>
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
    <mesh_term>Prednisolone</mesh_term>
    <mesh_term>Prednisolone hemisuccinate</mesh_term>
    <mesh_term>Prednisolone phosphate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
